Skip to main content

Table 3 Univariable and multivariable analysis of risk factors for carriage of any serotypeable pneumococcus among Aboriginal people in Western Australia, August 2008–November 2014

From: Predictors of pneumococcal carriage and the effect of the 13-valent pneumococcal conjugate vaccination in the Western Australian Aboriginal population

 

Odds Ratio (95% Confidence Interval)

Any pneumococcal serotype

Univariable

Multivariable

Male

1.56 (1.351.81)

0.81 (0.67–0.99)

Age increase by 12 months

 0–11 months

4.60 (2.837.50)

4.19 (2.397.33)

 1 to 19 yr

0.85 (0.840.87)

0.85 (0.840.87)

 20 + years

0.99 (0.98–1.01)

1.00 (0.99–1.02)

Annual increase

 Pre-PCV13

1.07 (0.98–1.18)

0.86 (0.750.98)

 Post-PCV13

0.88 (0.75–1.05)

1.37 (1.081.74)

Respiratory symptoms

1.48 (1.141.94)

1.01 (0.72–1.43)

Nasal discharge

4.84 (4.015.74)

2.49 (2.003.09)

Recent antibiotic use

0.73 (0.550.98)

0.48 (0.330.69)

Remoteness

 Metropolitan

Ref

Ref

 Regional

1.36 (0.97–1.89)

1.31 (0.88–1.96)

 Remote

1.86 (1.472.35)

2.21 (1.672.92)

ETS

1.24 (1.061.46)

1.06 (0.87–1.29)

≥5 people sharing (crowding)

1.35 (1.151.58)

1.36 (1.111.67)

Sharing with ≥1 child <5 years

1.15 (0.96–1.37)

1.07 (0.85–1.34)

Season

 Spring

Ref

Ref

 Summer

0.91 (0.66–1.27)

0.95 (0.62–1.45)

 Autumn

0.86 (0.70–1.07)

1.35 (0.91–2.00)

 Winter

1.29 (1.081.53)

1.11 (0.73–1.69)

H. influenzae

10.29 (8.6012.30)

N/A

M. catarrhalis

7.10 (6.018.39)

N/A

S. aureus

0.56 (0.440.72)

N/A

  1. Entries in italic considered statistically significant results